Kelly Zhang

Kelly Zhang serves as the Principal Scientist for Clinical Affairs and Toxicology at Church & Dwight, where she plays a pivotal role in advancing the scientific rigor behind the company's diverse product portfolio. With a focus on nutrition clinical trials, Kelly leads global initiatives that substantiate the efficacy and safety claims of a wide range of products, including regulated medical devices like Sterimar and Trojan, as well as over-the-counter solutions such as Arrid and Arm & Hammer Ultramax. Her expertise extends to wellness products, including Orajel and Vitafusion vitamins, where she employs her extensive knowledge in clinical research to ensure that these products meet the highest standards of safety and effectiveness.

Kelly's current projects highlight her commitment to innovative research methodologies. Notably, she has spearheaded bioequivalence studies examining the absorption of Vitamin D gummies versus tablets, contributing valuable insights to the field of nutritional science. Her published work in the journal Nutrients underscores her dedication to advancing our understanding of how different delivery forms impact nutrient bioavailability. Additionally, her randomized-controlled trials on Vitamin C bioequivalence further exemplify her ability to navigate complex clinical landscapes, ensuring that Church & Dwight's products are backed by robust scientific evidence.

With a strong foundation in life sciences and a deep understanding of FDA regulations, Kelly excels in cross-functional team leadership and CRO management. Her skills in biocompatibility and in vitro models for product testing enable her to drive innovative solutions in product development while maintaining compliance with industry standards. As a thought leader in clinical affairs, Kelly Zhang continues to shape the future of health and wellness products, ensuring that Church & Dwight remains at the forefront of scientific excellence in the consumer goods sector.